Clinical Trials in Georgia

Showing 8061-8080 of 19,050 trials

VAXCHORA Pediatric Study to Assess Safety and Immunogenicity

NCT03220737

VAXCHORA (Cholera Vaccine, Live, Oral) is a vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1. VAXCHORA is approved for use in adults 18 through 64 years of age travelling to cholera-affected areas. The primary goals of this Phase 4 study are to evaluate the safety and immunogenicity of a single dose of VAXCHORA (1 x 10e9 cfu/dose) in children ages 2 years to \<18 years of age in developed countries.

Cholera (Disorder)

Bavarian Nordic550 participantsStarted Jul 2017

Atlanta, Georgia, United States • Lenexa, Kansas, United States • Wichita, Kansas, United States +7 more locations

COMPLETEDPhase 365 miles

A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults

NCT02094586

The primary goal of this Phase III study is to compare 3 lots for consistency of manufacture.

Cholera

Bavarian Nordic3,146 participantsStarted May 2014

Mobile, Alabama, United States • Phoenix, Arizona, United States • DeLand, Florida, United States +22 more locations

VAXCHORA Pediatric Study to Assess Safety and Immunogenicity

A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults

Find Trials by Condition in Georgia

Nasal Decolonization of Dialysis Patients Noses

Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis

Standard vs Ultrasound-assisted Catheter Thrombolysis for Submassive Pulmonary Embolism

The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)

Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry

Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)

Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE

A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis

Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma

Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes

Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer

A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 to Treat Inflammation and Pain After Cataract Surgery

Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years

The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age

Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines

Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults

A Study of the Burden of Illness and Treatment Patterns in Teenagers and Adults With Hereditary Angioedema

International CoolSculpting: Study to Evaluate Patient Satisfaction for Non-Invasive Fat Reduction in Abdomen and/or Flanks (iCOOL)